MedTrace Logo

Addressing Personalized Needs in Clostridioides Difficile Infection

NCT04725123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2023-12-12

No results posted yet for this study

Summary

BEYOND is aiming to demonstrate how by enrichment of the available SPECIFY score, patients at great likelihood for CDI with unfavorable outcome are early detected

Conditions

  • Clostridioides Difficile Infection

Interventions

DIAGNOSTIC_TEST

Microbiome analysis

Stool microbiome analysis of 16S rRNA sequencing to an anticipated number of 8,000,000 reads

Sponsors & Collaborators

  • Hellenic Institute for the Study of Sepsis

    lead OTHER

Principal Investigators

  • Evangelos J Giamarellos-Bourboulis, MD, PhD · National and Kapodistrian University of Athens

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-26
Primary Completion
2022-03-27
Completion
2022-03-27

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04725123 on ClinicalTrials.gov